Eagle Pharmaceuticals, Inc.
METHODS OF USING DANTROLENE TO TREAT NERVE AGENT EXPOSURE

Abstract:

The disclosure is directed to methods of treating subjects exposed to nerve agents with dantrolene, or a pharmaceutically acceptable salt thereof.